This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bailey, C. J Articles by Barnett, A. H Search for Related Content Social Bookmarking                         What's this?

Exubera expires

Diabetes Research Group School of Life and Health Sciences, Aston University Aston Triangle, Birmingham, B4 7ET, UK, c.j.bailey{at}aston.ac.uk

Caroline Day

Diabetes Research Group School of Life and Health Sciences, Aston University Aston Triangle, Birmingham, B4 7ET, UK

Anthony H Barnett

Department of Medicine, Undergraduate Centre Heart of England NHS Foundation Trust, Bordesley Green East, UK

References

• Exubera website. http://www.exubera.com/content/Questions.jsp (Accessed November 2007)
• Freemantle N., Blonde L., Duhot D. et al. Availability of inhaled insulin promotes greater perceived acceptance of insulin therapy in patients with type 2 diabetes. Diabetes Care 2005;28:427-8.[Free Full Text]
• Bellary S., Barnett AH Inhaled insulin: overcoming barriers to insulin therapy? Br J Diabetes Vasc Dis 2006;6:103-08.[Abstract/Free Full Text]
• Barnett AH, Lange P., Dreyer M. et al. Long term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes. Int J Clin Pract 2007;61:1614-25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Skyler JS, Jovanovic L., Klioze S. et al. Two-year safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1 diabetes. Diabetes Care 2007;30:579-85.[Abstract/Free Full Text]
• Rosenstock J., Capelleri JC, Bolinder B., Gerber RA Patient satisfaction and glycaemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes. Diabetes Care 2004;27:1318-23.[Abstract/Free Full Text]
• Ceglia L., Lau J., Pittas AG Meta-analysis: efficacy and safety of inhaled insulin therapy in adults with diabetes mellitus. Ann Intern Med 2006;145:665-75.[Abstract/Free Full Text]
• Day C. Glycaemic control with advanced new insulins for the treatment of diabetes. Eur Diabetes Nursing 2006;3:117-22.[CrossRef]
• NICE technology appraisal guidance, 113. Inhaled insulin for the treatment for diabetes (type 1 and 2) National Institute for health and Clinical Excellence. 2006. www.nice.org.uk/TA113 (Accessed Oct 2007)

The British Journal of Diabetes & Vascular Disease, Vol. 7, No. 6, 255-256 (2007)
DOI: 10.1177/14746514070070060101


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bailey, C. J Articles by Barnett, A. H Search for Related Content Social Bookmarking                         What's this?